4(beta-benzoylvinyl)-antipyrine derivatives after antiphlogistic and analgesic activity.
D000098:Acetophenones / Q000633:toxicity; D000632:Aminopyrine / Q000494:pharmacology / Q000633:toxicity; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology; D000983:Antipyrine / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D000996:Antitussive Agents / Q000494:pharmacology; D003331:Coronary Vessels / Q000187:drug effects; D004487:Edema / Q000517:prevention & control; D005557:Formaldehyde / Q000037:antagonists & inhibitors; D051379:Mice; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology / Q000633:toxicity; D011427:Propiophenones; D011720:Pyrazoles; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology
D000098:Acetophenones; D000700:Analgesics; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000996:Antitussive Agents; D009125:Muscle Relaxants, Central; D011427:Propiophenones; D011720:Pyrazoles; D014665:Vasodilator Agents; D000632:Aminopyrine; D005557:Formaldehyde; D010653:Phenylbutazone; D000983:Antipyrine